Fulltext

Informing pneumococcal conjugate vaccine policy in middle-income countries: The case of Malaysia

Tricarico S 1 , McNeil HC 1 , Head MG 2 , Cleary DW 3 , Clarke SC 4 , MYCarriage

Affiliations 

  • 1 Faculty of Medicine, Infectious Disease Epidemiology Group, University of Southampton, Mailpoint 814, Level C, Sir Henry Wellcome Laboratories, South Block, University Hospital Southampton Foundation NHS Trust, Southampton SO16 6YD, UK; University of Southampton Malaysia Campus, No. 3, Persiaran Canselor, 1, Kota Ilmu, Educity, Iskandar, 79200 Nusajaya, Johor, Malaysia
  • 2 Faculty of Medicine, Infectious Disease Epidemiology Group, University of Southampton, Mailpoint 814, Level C, Sir Henry Wellcome Laboratories, South Block, University Hospital Southampton Foundation NHS Trust, Southampton SO16 6YD, UK; Global Health Research Institute, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK
  • 3 Faculty of Medicine, Infectious Disease Epidemiology Group, University of Southampton, Mailpoint 814, Level C, Sir Henry Wellcome Laboratories, South Block, University Hospital Southampton Foundation NHS Trust, Southampton SO16 6YD, UK
  • 4 Faculty of Medicine, Infectious Disease Epidemiology Group, University of Southampton, Mailpoint 814, Level C, Sir Henry Wellcome Laboratories, South Block, University Hospital Southampton Foundation NHS Trust, Southampton SO16 6YD, UK; University of Southampton Malaysia Campus, No. 3, Persiaran Canselor, 1, Kota Ilmu, Educity, Iskandar, 79200 Nusajaya, Johor, Malaysia; Global Health Research Institute, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. Electronic address: [email protected]
Vaccine, 2017 04 25;35(18):2288-2290.
PMID: 28347503 DOI: 10.1016/j.vaccine.2017.03.053

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications